Starting a new medication during active disease makes it harder to distinguish medication effects from disease activity and could potentially complicate flare management
Whole-body cryotherapy has been associated with improved circulation and decreased inflammatory markers (Hohenauer et al., 2020)
Short-acting GLP-1 agents like exenatide immediate-release (Byetta) and lixisenatide (Adlyxin) must be administered within 60 minutes before meals
Mari A., Degn K., Brock B., Rungby J., Ferrannini E., Schmitz O
The pentadecapeptide BPC-157 (GEPPPGKPADDAGLV) shows a protective effect on stomach and duodenum when administered to stress ulcers, cysteamine-duodenal ulcers and ethanol lesions
It encourages the activity of tendon fibroblasts, aiding in the repair of traumatic injuries and endothelium damage